AAAAAA

   
Results: 1-10 |
Results: 10
ORAL TOPOTECAN GIVEN ONCE OR TWICE-DAILY FOR 10 DAYS - A PHASE-I PHARMACOLOGY STUDY IN ADULT PATIENTS WITH SOLID TUMORS
Authors: GERRITS GJH BURRIS H SCHELLENS JHM ECKARDT JR PLANTING AST VANDERBURG MEL RODRIGUEZ GI LOOS WJ VANBEURDEN V HUDSON I FIELDS S VONHOFF DD VERWEIJ J
Citation: Gjh. Gerrits et al., ORAL TOPOTECAN GIVEN ONCE OR TWICE-DAILY FOR 10 DAYS - A PHASE-I PHARMACOLOGY STUDY IN ADULT PATIENTS WITH SOLID TUMORS, Clinical cancer research, 4(5), 1998, pp. 1153-1158
ORAL TOPOTECAN GIVEN ONCE OR TWICE-DAILY FOR 10 DAYS - A PHASE-I PHARMACOLOGY STUDY IN ADULT PATIENTS WITH SOLID TUMORS
Authors: GERRITS GJH BURRIS H SCHELLENS JHM ECKARDT JR PLANTING AST VANDERBURG MEL RODRIGUEZ GI LOOS WJ VANBEURDEN V HUDSON I FIELDS S VONHOFF DD VERWEIJ J
Citation: Gjh. Gerrits et al., ORAL TOPOTECAN GIVEN ONCE OR TWICE-DAILY FOR 10 DAYS - A PHASE-I PHARMACOLOGY STUDY IN ADULT PATIENTS WITH SOLID TUMORS, Clinical cancer research, 4(5), 1998, pp. 1153-1158
5 DAYS OF ORAL TOPOTECAN (HYCAMTIN(R)), A PHASE-I AND PHARMACOLOGICALSTUDY IN ADULT PATIENTS WITH SOLID TUMORS
Authors: GERRITS CJH BURRIS H SCHELLENS JHM PLANTING AST VANDENBURG MEL RODRIGUEZ GI VANBEURDEN V LOOS WJ HUDSON I FIELDS S VERWEIJ J VONHOFF DD
Citation: Cjh. Gerrits et al., 5 DAYS OF ORAL TOPOTECAN (HYCAMTIN(R)), A PHASE-I AND PHARMACOLOGICALSTUDY IN ADULT PATIENTS WITH SOLID TUMORS, European journal of cancer, 34(7), 1998, pp. 1030-1035
PHASE-I AND PHARMACOLOGICAL STUDY ON ORAL [PEG-1000] 9-AMINO-CAMPTOTHECIN (9-AC) IN PATIENTS WITH ADVANCED SOLID TUMORS
Authors: DEJONGE MJA PUNT CJA SPARREBOOM A LOOS WJ VANBEURDEN V PLANTING AST DALLAIRE B VERWEIJ J
Citation: Mja. Dejonge et al., PHASE-I AND PHARMACOLOGICAL STUDY ON ORAL [PEG-1000] 9-AMINO-CAMPTOTHECIN (9-AC) IN PATIENTS WITH ADVANCED SOLID TUMORS, Annals of oncology, 9, 1998, pp. 243-243
PHASE ONE PHARMACOKINETIC STUDY OF CGS27023A, A MATRIX METALLOPROTEINASE INHIBITOR
Authors: LEVITTL NC ESKENS F PROPPER DJ HARRIS AL DENIS L GANESAN TS MATHER RA MCKINLEY L PLANTING A TALBOT DC VANBEURDEN V VANDERBURG M WILNER S VERWEIJ J
Citation: Nc. Levittl et al., PHASE ONE PHARMACOKINETIC STUDY OF CGS27023A, A MATRIX METALLOPROTEINASE INHIBITOR, British Journal of Cancer, 78, 1998, pp. 23-23
A PHASE-I PHASE-II STUDY OF MULTICYCLIC DOSE-INTENSIVE CHEMOTHERAPY SUPPORTED WITH G-CSF, OR G-CSF AND HEMATOPOIETIC PROGENITOR CELLS IN WHOLE-BLOOD, IN 2 CONSECUTIVE COHORTS OF PATIENTS/
Authors: DEWIT R KRUIT WHJ LAMERS CHJ VANTVEER MB LUYTEN AA VANBEURDEN V HARTEVELD M PLANTING AST SCHMITZ PIM STOTER G BOLHUIS RLH VERWEIJ J
Citation: R. Dewit et al., A PHASE-I PHASE-II STUDY OF MULTICYCLIC DOSE-INTENSIVE CHEMOTHERAPY SUPPORTED WITH G-CSF, OR G-CSF AND HEMATOPOIETIC PROGENITOR CELLS IN WHOLE-BLOOD, IN 2 CONSECUTIVE COHORTS OF PATIENTS/, British Journal of Cancer, 77(12), 1998, pp. 2363-2366
A COMPARISON OF CLINICAL PHARMACODYNAMICS OF DIFFERENT ADMINISTRATIONSCHEDULES OF ORAL TOPOTECAN (TPT, HYCAMTIN(R))
Authors: GERRITS C SCHELLENS J BURRIS H PLANTING A VANDERBURG M VANBEURDEN V LOOS W HUDSON I FIELDS S VONHOFF D VERWEIJ J
Citation: C. Gerrits et al., A COMPARISON OF CLINICAL PHARMACODYNAMICS OF DIFFERENT ADMINISTRATIONSCHEDULES OF ORAL TOPOTECAN (TPT, HYCAMTIN(R)), European journal of cancer, 33, 1997, pp. 1105-1105
PHARMACOKINETICS AND ORAL BIOAVAILABILITY OF 9-AMINO-CAMPTOTHECIN PEG1000 CAPSULES
Authors: SPARREBOORN A DEJONGE MJA LOOS WJ VANBEURDEN V PUNT CJA PLANTING AST VANDERBURG MEL COLAJORI E VERWEIJ J
Citation: A. Sparreboorn et al., PHARMACOKINETICS AND ORAL BIOAVAILABILITY OF 9-AMINO-CAMPTOTHECIN PEG1000 CAPSULES, European journal of cancer, 33, 1997, pp. 1112-1112
PHASE-I AND PHARMACOKINETIC (PK) STUDY OF IRINOTECAN (CPT-11) AND CISPLATIN IN PATIENTS WITH SOLID TUMORS - PRELIMINARY-RESULTS
Authors: DEJONGE MJA SPARREBOOM A PLANTING AST VANDERBURG MEL DEBRUIJN P BROUWER E VANBEURDEN V VANDUIJN MR JACQUES C VERWEIJ J
Citation: Mja. Dejonge et al., PHASE-I AND PHARMACOKINETIC (PK) STUDY OF IRINOTECAN (CPT-11) AND CISPLATIN IN PATIENTS WITH SOLID TUMORS - PRELIMINARY-RESULTS, European journal of cancer, 33, 1997, pp. 1134-1134
PATIENT PERCEPTIONS OF THE SIDE-EFFECTS OF CHEMOTHERAPY - THE INFLUENCE OF 5HT3 ANTAGONISTS
Authors: DEBOERDENNERT M DEWIT R SCHMITZ PIM DJONTONO J VANBEURDEN V STOTER G VERWEIJ J
Citation: M. Deboerdennert et al., PATIENT PERCEPTIONS OF THE SIDE-EFFECTS OF CHEMOTHERAPY - THE INFLUENCE OF 5HT3 ANTAGONISTS, British Journal of Cancer, 76(8), 1997, pp. 1055-1061
Risultati: 1-10 |